Technetium-99m-methylene disphosphonate (MDP) bone scan hypercalcemia.
Multifocal pyomyositis. Diagnosis on technetium-99m MDP bone scan.
Gallbladder visualization on a technetium-99m MDP bone scan.
Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate ((99m)Tc-HMDP) Bone Scintigraphy for Bone Metastases from Prostate Cancer Using Deep Learning Algorithms.
Higashiyama S, Yoshida A, Kawabe J.
Curr Med Imaging. 2021;17(1):89-96. doi: 10.2174/1573405616666200528153453.
Technetium-99m APD compared with technetium-99m MDP as a bone scanning agent.
Degrossi OJ, Oliveri P, García del Río H, Labriola R, Artagaveytía D, Degrossi EB.
J Nucl Med. 1985 Oct;26(10):1135-9.
Adverse Clinical Events at the Injection Site Are Exceedingly Rare After Reported Radiopharmaceutical Extravasation in Patients Undergoing (99m)Tc-MDP Whole-Body Bone Scintigraphy: A 12-Year Experience.
Parihar AS, Schmidt LR, Crandall J, Dehdashti F, Wahl RL.
J Nucl Med. 2023 Mar;64(3):485-490. doi: 10.2967/jnumed.122.264994. Epub 2022 Oct 20.
Altered Distribution of 99m Tc-MDP Bone Scintigraphy : Still Room Left for 99m Tc-Dextrose Interference?
Sharifian A, Qutbi M.
Clin Nucl Med. 2023 Sep 1;48(9):837-838. doi: 10.1097/RLU.0000000000004548. Epub 2023 Jan 14.
Three phase bone scintigraphy with (99m)Tc-MDP and serological indices in detecting infection after internal fixation in malunion or nonunion traumatic fractures.
Yang F, Yang Z, Feng J, Zhang L, Ma D, Yang J.
Hell J Nucl Med. 2016 May-Aug;19(2):130-4. doi: 10.1967/s002449910366. Epub 2016 Jun 22.
Technetium-99m MDP vs technetium-99m dicarboxypropane diphosphonate. A clinical comparison in various pathologic conditions.
Godart G, Durez M, Bevilacqua M, Abramovici J, Robience Y.
Clin Nucl Med. 1986 Feb;11(2):92-7. doi: 10.1097/00003072-198602000-00006.
Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
Gulenchyn KY, Papoff W.
Clin Nucl Med. 1987 Jan;12(1):45-6.
Localization of technetium-99m methylene diphosphonate in bone using microautoradiography.
Einhorn TA, Vigorita VJ, Aaron A.
J Orthop Res. 1986;4(2):180-7. doi: 10.1002/jor.1100040206.
Technetium-99m-alendronate: a new radiopharmaceutical for bone scanning.
Arteaga de Murphy C, Meléndez-Alafort L, Montoya-Molina C, Sepúlveda-Méndez J.
Arch Med Res. 1996 Winter;27(4):481-3.
Preparation and in vivo biological investigations on a novel radioligand for bone scanning: technetium-99m-labeled zoledronic acid derivative.
Lin J, Qiu L, Cheng W, Luo S, Ye W.
Nucl Med Biol. 2011 Jul;38(5):619-29. doi: 10.1016/j.nucmedbio.2010.12.005. Epub 2011 Mar 3.
